Day: February 24, 2022

TORONTO, Feb. 24, 2022 (GLOBE NEWSWIRE) — ARHT Media Inc. (“ARHT Media“) [TSXV:ART], the global leader in the development, production and distribution of high-quality, low latency hologram and digital content, announces today that it has granted an aggregate of 600,000 options to two directors pursuant to the Company’s stock option plan. The stock options vest in the following schedule: 1/3 immediately, 1/3 on the first anniversary of the grant; and 1/3 on the second anniversary of the grant, and may be exercised at a price of $0.245 for a period of five years from the date of grant. The grant of options is subject to the approval of the TSX Venture Exchange. ARHT would also like to announce the resignation of Kwok Hei (Benjamin) Yam from the board of directors. Larry O’Reilly said, “We would like...

Revisiting the risk of tardive dyskinesia with metoclopramide use in diabetic gastroparesis: results of a real-world data driven epidemiology study SOLANA BEACH, Calif., and CHICAGO, Feb. 24, 2022 (GLOBE NEWSWIRE) — Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on Gimoti (metoclopramide) nasal spray (GIMOTI), today announced that the results of a retrospective analysis of United States (US) administrative claims data that examined the association between tardive dyskinesia (TD) and potential risk factors will be presented at the annual Digestive Disease Week Meeting in San Diego, CA taking place from May 21-24, 2022. Evoke’s flagship product, GIMOTI, is an FDA-approved novel nasal formulation of metoclopramide commercially...

Carrollton, Texas, Feb. 24, 2022 (GLOBE NEWSWIRE) — Allied Energy Corp (OTC Pink: AGYP), is a producing oil and gas company focused on leasing and reworking of oil and gas reserves in one of the most prolific hydrocarbon areas in the United States. Allied Energy is pleased to announce that the Company has retained the services of a securities council to assist the company “AGYP” in the process of up-listing to a recognized North American Stock Exchange, excluding the US OTCMarkets. Furthermore, council has also been secured to advise and help structure an ongoing share buyback program of AGYP’s common stock. Council retained by Allied has practiced securities law for over 30 years in North America and has successfully helped companies list and up-list their securities from lower tiered exchanges to higher tiered exchanges....

FORT LAUDERDALE, FL, Feb. 24, 2022 (GLOBE NEWSWIRE) — SFLMaven Corp. (OTC Pink: SFLM), (“SFLMaven” or the “Company”) (www.sflmaven.com), a leading provider of high-end luxury goods, is pleased to provide current and prospective shareholders with an update on performance as well as qualitative and quantitative guidance for the Company’s outlook ahead. “When we closed last year, we pointed to a number of key tailwinds driving our jewelry business that could factor into accelerating growth in 2022,” stated Joseph Ladin, CEO of SFLMaven. “So far, that seems to be playing out this year, with our Q1 performance putting us on pace for double-digit organic growth, which helps to lay a sturdy foundation as we expand into new domains, including non-fungible tokens and the Metaverse.” Management notes that the Company...

Newly published data demonstrates substantial cross-reactivity against multiple variants of COVID-19 S-only candidate is believed to be the first to demonstrate robust neutralizing antibody responses in mucosal sites, which is where primary infection occurs Vaxart’s S-only candidate induced a 1000-fold increase in nasal IgA responses to the variants, which could have substantial impact on reducing community transmission SOUTH SAN FRANCISCO, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) — A new study published on BioRxiv.org demonstrates that Vaxart’s S-only COVID-19 clinical vaccine candidate, now being studied by Vaxart in Phase II trials, generated antibodies to the original COVID-19 virus strain and to the beta, delta, alpha and gamma variants of SARS-CoV-2 in the serum and nasal mucosa of non-human primates (NHPs). The NHP results...

Figure 1 Alaska Project Location Map. Current projects have gold marker. Former projects have black marker.Figure 2 Project locations in which Millrock has ownership and / or royalty interests.Key Highlights – Anticipated 2022 Activity:Drilling on at least four and perhaps as many as eight projects in which Millrock has equity and royalty interests.Treasure Creek, Ester, Fairbanks district, Liberty Bell gold projects, Fairbanks area, Alaska (Felix Gold 15,000 meters planned). 64North gold project, Pogo Mine area, Alaska (Resolution Minerals, planning in progress). Apex El Nido gold project, southeast Alaska (Coeur Explorations, 1,500 meters under consideration). Batamote copper project, Sonora Mexico (Mine Discovery Fund earning in, preliminary planning in progress). El Picacho gold project, Sonora Mexico (Tocvan Ventures, preliminary...

Delivers security, operational efficiency, and cost benefits unmatched by traditional identity frameworks Atlanta , Feb. 24, 2022 (GLOBE NEWSWIRE) — Trust Stamp (Nasdaq: IDAI, Euronext Growth: AIID ID), the Privacy-First Identity CompanyTM providing AI-powered trust and identity services used globally across multiple sectors, announces the launch of its end-to-end Identity Orchestration Platform, which streamlines delivery and implementation of the Company’s proven technologies through a low-code approach. Trust Stamp’s powerful identity platform enables clients to transform security, privacy, and usability in digital operations with a range of leading AI-powered technologies including biometric, document and liveness verification, as well as data-protection and more, in order to support robust identity frameworks that can be established,...

Ceremony Recognizes Importance of Biopharma Industry and Advocacy Group Collaboration to Address Needs for New Treatments in Orphan and Rare Disorders Together, Will Ring the Nasdaq Opening Bell to Kick-Off Rare Disease Day on February 28, 2022 CORAL GABLES, Fla., Feb. 24, 2022 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare diseases, today announced that the company is standing with the National Organization for Rare Disorders (NORD), Global Genes, Muscular Dystrophy Association, Myasthenia Gravis Foundation of America, Conquer MG, and Myasthenia Gravis Association, to ring the opening bell of the Nasdaq market on international...

SAN DIEGO, Feb. 24, 2022 (GLOBE NEWSWIRE) — Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced that Todd R. Nelson, PhD, the company’s chief executive officer, will present virtually at the 42nd Annual Cowen Healthcare Conference on Wednesday, March 9th at 2:10 pm Eastern time / 11:10 am Pacific Time. Additionally, Todd will participate in a ‘Synthetic Biology Enabling Technologies Panel’ on Monday, March 7th at 10:30 am Eastern time / 7:30 am Pacific Time. The presentation and panel discussion will both be webcast live and can be accessed through a link on the investors section of Codex DNA’s website at https://ir.codexdna.com. An archived replay of each webcast will be available for 30 days following the event. About Codex DNACodex DNA is empowering scientists with the ability...